| Search Weight Loss Topics: |
Weight Loss Programs Market 2020: Potential Growth, Challenges, and Know the Companies List Could Potentially Benefit or Loose out From the Impact of…
Long Term Weight Loss 
Comments Off on Weight Loss Programs Market 2020: Potential Growth, Challenges, and Know the Companies List Could Potentially Benefit or Loose out From the Impact of…
Weight Loss Programs Market Reports provide results and potential opportunities and challenges to future Weight Loss Programs industry growth. Weight Loss Programs market research reports offers five-year revenue forecasts through 2024 within key segments of the Weight Loss Programs industry.
The Global Weight Loss Programs Market is poised to grow strong during the forecast period 2017 to 2026. Weight Loss Programs market is the definitive study of the global Weight Loss Programs industry. The report content includes technology, industry drivers, geographic trends, market statistics, market forecasts, producers, and raw material/equipment suppliers.
If you are planning to invest into new products or trying to understand this growing market, this report is your starting point.Get Exclusive Sample PDF Copy:https://inforgrowth.com/sample-request/6477711/weight-loss-programs-market
The Weight Loss Programs industry study concludes with a list of leading companies/suppliers operating in this industry at different stages of the value chain.
Major Classifications of Weight Loss Programs Market:
Major Key players covered in this report:
By Product Type:
By Applications:
HALLOWEEN OFFER: Get up-to 30% Extra Discount for this Exclusive Gene Synthesis Service Market Report,https://inforgrowth.com/discount/6477711/weight-loss-programs-market
The Weight Loss Programs market research report provides a concise and clear overview of this complex and often dynamic industry. The report dives into the trends in the specialty Weight Loss Programs industry by looking at the market from a regional perspective, application perspective, and materials point of view. As a market with significant growth potential, we look not only at the market today, but also at how it will develop over the next three years and the trends and developments that will drive growth.
Weight Loss Programs Market Overview:
Impact of COVID-19:Weight Loss Programs Market report analyses the impact of Coronavirus (COVID-19) on the Weight Loss Programs industry. Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 180+ countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Weight Loss Programs market in 2020.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; emergency declared in many countries; massive slowing of the supply chain; stock market unpredictability; falling business assurance, growing panic among the population, and uncertainty about future.
COVID-19 can affect the global economy in 3 main ways: by directly affecting production and demand, by creating supply chain and market disturbance, and by its financial impact on firms and financial markets.
Get Sample Table of Content PDF of COVID-19/CoronaVirus Impact Analysis of Weight Loss Programs Market 2020.https://inforgrowth.com/CovidImpact-Request/6477711/weight-loss-programs-market
Why Buy This Weight Loss Programs Market Report?
Get accurate data and strategic insights on the worldwide Weight Loss Programs market & key players.
What is the market share and respective growth rate between the various application segments? Between developed and emerging economic regions?
Apprehend the magnitude of latest manufacturing trends (future trends, upcoming technologies etc).
As global capacity for and production in Weight Loss Programs market to increase, which geographic regions will have the largest volume and highest growth rates for Weight Loss Programs consumption?
For investors & private equity firms: identify the best companies to invest in.
FOR ALL YOUR RESEARCH NEEDS, REACH OUT TO US AT:Address: 6400 Village Pkwy suite # 104, Dublin, CA 94568, USAContact Name: Rohan S.Email:[emailprotected]Phone: +1-909-329-2808UK: +44 (203) 743 1898
Read the original:
Weight Loss Programs Market 2020: Potential Growth, Challenges, and Know the Companies List Could Potentially Benefit or Loose out From the Impact of...
Novartis Cosentyx shows early synovitis reduction in patients with psoriatic arthritis in first-of-its-kind study – BioSpace
Long Term Weight Loss Comments Off on Novartis Cosentyx shows early synovitis reduction in patients with psoriatic arthritis in first-of-its-kind study – BioSpace
EAST HANOVER, N.J., Nov. 5, 2020 /PRNewswire/ -- Novartis, a leader in rheumatology and immuno-dermatology, today announced 12-week results from the first-of-its-kind Phase IIIb ULTIMATE randomized controlled trial, which demonstrated the significant treatment response of Cosentyx (secukinumab) on synovitis (joint lining inflammation) in psoriatic arthritis (PsA) versus placebo. Synovitis was assessed using an advanced and sensitive imaging technique called Power Doppler ultrasonography (PDUS). These data are being presented at the American College of Rheumatology (ACR) All-Virtual Annual Meeting, November 5-9, 2020.
"Psoriatic arthritis can have a significant impact on a patient's joints. Joint lining inflammation, also known as synovitis, if left untreated, can cause pain to worsen, joint damage and may decrease physical function," said Dr. Maria A. D'Agostino, Professor of Rheumatology at the Catholic University of Rome. "These data are highly encouraging, showing Cosentyx can significantly reduce synovitis at Week 12 versus placebo with results seen as early as Week 1, and that ultrasound is a sensitive and objective tool to monitor joint inflammation in PsA patients."
The use of a standardized ultrasound synovitis score (GLOESS) as the primary endpoint showed objectively the significant benefit of Cosentyx versus placebo on synovitis at Week 12 with an early improvement observed from Week one. Treatment with Cosentyx also significantly improved key secondary endpoints versus placebo, including ACR20 (68% vs 34%, respectively), ACR50 (46% vs 9%, respectively) and enthesitis (mean change from baseline in Spondyloarthritis Research Consortium of Canada enthesitis index score [SPARCC] of -2.4 vs -1.7 respectively)1. The safety profile of Cosentyx through 12 weeks was consistent with previous studies1.
Novartis anticipates disclosing full 24-week data from the ongoing ULTIMATE trial at the European League Against Rheumatism (EULAR) annual meeting in 2021 and final analysis at ACR 2021.
"As a strong believer in the diagnostic and treatment monitoring benefits of ultrasound, this first large randomized double-blind placebo-controlled clinical trial in PsA with an ultrasonographic primary endpoint is incredibly exciting. The ability to use a sensitive imaging technique to assess synovitis and enthesitis in PsA represents a breakthrough in how we conceptualize treatment goals," said Dr. Catherine Bakewell of Intermountain Medical Group in Salt Lake City, UT and an investigator in the ULTIMATE study. "In addition to other measures, PDUS helps to provide earlier insight into treatment response and that patients are more effectively treated across multiple domains of this heterogeneous psoriatic disease spectrum."
PsA is a complex disease with multiple manifestations driving patient symptoms3,4. In PsA, synovitis may lead to joint damage and if left untreated, the joint damage can be irreversible5,6. In addition to reducing synovitis, Cosentyx has been proven to provide long-lasting inhibition of radiographic progression in PsA, limiting joint damage and helping to improve outcomes for patients with this debilitating condition7,8.
About Psoriatic Arthritis (PsA)PsA is estimated to affect up to 50 million people worldwide9,10. It is part of a family of life-long inflammatory diseases (spondyloarthritis) that target the joints and is closely associated with psoriasis10. Up to 40% of patients with psoriasis may develop PsA10. Symptoms of PsA include joint pain and stiffness, skin and nail psoriasis, swollen toes and fingers, persistent painful swelling of the tendons and irreversible joint damage10.
About ULTIMATE ULTIMATE is the first ongoing 52-week double-blind, placebo-controlled Phase IIIb study using ultrasound to assess time-course of response of Cosentyx on synovitis in psoriatic arthritis. The study enrolled 166 adult biologic-nave patients with active Psoriatic arthritis. Patients were randomized (1:1) to receive either secukinumab (300-mg or 150-mg according to severity of skin disease) or placebo weekly for a month with treatment starting at Week 4, followed by a once-a-month dose for the next 11 months.
The primary endpoint is the difference in mean change from baseline to Week 12 between secukinumab and placebo in Global Omeract-European League Against Rheumatism Ultrasound Synovitis Score (GLOESS). GLOESS is a standardized composite score that has shown to be sensitive to change and able to detect and score synovitis11. Secondary endpoints include ACR20, ACR50 and change in Spondyloarthritis Research Consortium of Canada (SPARCC) enthesitis index from baseline to Week 12 compared with placebo.
ACR20 and ACR50 are composite measures defined as both improvement of 20% or 50% in the number of tender and number of swollen joints, and a 20% or 50% improvement in three of the following five criteria: patient global assessment, physician global assessment, Health Assessment Questionnaire, visual analog pain scale and erythrocyte sedimentation rate or C-reactive protein12. The SPARCC enthesitis index is a validated clinical tool for evaluation of enthesitis13,14.
About Cosentyx (secukinumab)Cosentyx is the first and only fully-human biologic that directly inhibits interleukin-17A (IL-17A), an important cytokine involved in the inflammation and development of psoriatic arthritis (PsA), moderate to severe plaque psoriasis (PsO), ankylosing spondylitis (AS) and nr-axSpA15,16. Cosentyx has been studied clinically for more than 13 years. The medicine is backed by robust investigational evidence, including five years of clinical data supporting long-term safety and efficacy across moderate to severe plaque psoriasis (PsO), psoriatic arthritis (PsA) and ankylosing spondylitis (AS)17-22,23. These data strengthen the unique position of Cosentyx as a comprehensive treatment across axial spondyloarthritis, psoriatic arthritis and psoriatic disease, supported by more than 400,000 patients treated worldwide since launch2,23,24.
IMPORTANT SAFETY INFORMATIONDo not use COSENTYX if you have had a severe allergic reaction to secukinumab or any of the other ingredients in COSENTYX. See the Medication Guide for a complete list of ingredients.
COSENTYX is a medicine that affects your immune system. COSENTYX may increase your risk of having serious side effects such as:
InfectionsCOSENTYX may lower the ability of your immune system to fight infections and may increase your risk of infections.
Before starting COSENTYX, tell your doctor if you:
After starting COSENTYX, call your doctor right away if you have any signs of infection listed above. Do not use COSENTYX if you have any signs of infection unless you are instructed to by your doctor.
Inflammatory Bowel DiseaseNew cases of inflammatory bowel disease or "flare-ups" can happen with COSENTYX, and can sometimes be serious. If you have inflammatory bowel disease (ulcerative colitis or Crohn's disease), tell your doctor if you have worsening disease symptoms during treatment with COSENTYX or develop new symptoms of stomach pain or diarrhea.
Serious Allergic ReactionsSerious allergic reactions can occur. Get emergency medical help right away if you get any of the following symptoms: feeling faint; swelling of your face, eyelids, lips, mouth, tongue, or throat; trouble breathing or throat tightness; chest tightness; or skin rash. If you have a severe allergic reaction, do not give another injection of COSENTYX.
Before starting COSENTYX, tell your doctor if you:
Tell your doctor about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Know the medicines you take. Keep a list of your medicines to show your doctor and pharmacist when you get a new medicine.
How should I use COSENTYX?See the detailed Instructions for Use that comes with your COSENTYX for information on how to prepare and inject a dose of COSENTYX, and how to properly throw away (dispose of) used COSENTYX Sensoready pens and prefilled syringes.
The most common side effects of COSENTYX include: cold symptoms, diarrhea, and upper respiratory infections. These are not all of the possible side effects of COSENTYX. Call your doctor for medical advice about side effects.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit http://www.fda.gov/medwatch, or call 1-800-FDA-1088.
Please see full Prescribing Information, including Medication Guide.
DisclaimerThis press release contains forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements can generally be identified by words such as "potential," "can," "will," "plan," "may," "could," "would," "expect," "anticipate," "look forward," "believe," "committed," "investigational," "pipeline," "launch," or similar terms, or by express or implied discussions regarding potential marketing approvals, new indications or labeling for the investigational or approved products described in this press release, or regarding potential future revenues from such products. You should not place undue reliance on these statements. Such forward-looking statements are based on our current beliefs and expectations regarding future events, and are subject to significant known and unknown risks and uncertainties. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those set forth in the forward-looking statements. There can be no guarantee that the investigational or approved products described in this press release will be submitted or approved for sale or for any additional indications or labeling in any market, or at any particular time. Nor can there be any guarantee that such products will be commercially successful in the future. In particular, our expectations regarding such products could be affected by, among other things, the uncertainties inherent in research and development, including clinical trial results and additional analysis of existing clinical data; regulatory actions or delays or government regulation generally; global trends toward health care cost containment, including government, payor and general public pricing and reimbursement pressures and requirements for increased pricing transparency; our ability to obtain or maintain proprietary intellectual property protection; the particular prescribing preferences of physicians and patients; general political, economic and business conditions, including the effects of and efforts to mitigate pandemic diseases such as COVID-19; safety, quality, data integrity or manufacturing issues; potential or actual data security and data privacy breaches, or disruptions of our information technology systems, and other risks and factors referred to in Novartis AG's current Form 20-F on file with the US Securities and Exchange Commission. Novartis is providing the information in this press release as of this date and does not undertake any obligation to update any forward-looking statements contained in this press release as a result of new information, future events or otherwise.
About NovartisLocated in East Hanover, NJ Novartis Pharmaceuticals Corporation an affiliate of Novartis is reimagining medicine to improve and extend people's lives. As a leading global medicines company, we use innovative science and digital technologies to create transformative treatments in areas of great medical need. In our quest to find new medicines, we consistently rank among the world's top companies investing in research and development. Novartis employs more than 15,000 people in the United States. For more information, please visit https://www.novartis.us.
Novartis and Novartis US is on Twitter. Sign up to follow @Novartis at https://twitter.com/novartisnews and @NovartisUS at https://twitter.com/NovartisUS.For Novartis multimedia content, please visit https://www.novartis.com/news/media-libraryFor questions about the site or required registration, please contact media.relations@novartis.com.
References
1.
D'Agostino MA, Schett G, Lpez-Rdz A, et al. Secukinumab significantly decreased joint synovitis measured by power Doppler ultrasonography in biologic nave patients with active psoriatic arthritis: primary (12-week) results from a randomized, placebo-controlled Phase III study. Abstract presented at the American College of Rheumatology (ACR) Convergence 2020: The ACR's All-Virtual Annual Meeting.
2.
Data on file. COSENTYX access. Novartis Pharmaceuticals Corp; July 2020.
3.
Ritchin CT, Colbert RA, Gladman DD. Psoriatic arthritis. N Engl J Med. 2017;376(10):957-970.
4.
Kavanaugh A, Helliwell P, Ritchlin CT. Psoriatic arthritis and burden of disease: patient perspectives from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis (MAPP) survey. Rheumotol Ther. 2016;3(1):91-102.
5.
Van Kuijk A, Tak P. Synovitis in psoriatic arthritis: immunochemistry, comparisons with rheumatoid arthritis and effects of therapy. Curr Rheumatol Rep. 2011;13:353-359.
6.
Celis R, Cuervo A, Ramirez J, et al. Psoriatic synovitis: singularity and potential clinical implications. Frontiers in Medicine. 2019;6:1-7
7.
Mease P, van der Heijde D, Landew R, et al. Secukinumab improves active psoriatic arthritis symptoms and inhibits radiographic progression: primary results from the randomised, double-blind, phase III FUTURE 5 study Annals of the Rheumatic Diseases 2018;77:890-897.
8.
Van Der Heijde D, Mease PJ, Landewe R, et al. Secukinumab provides sustained low rates of radiographic progression in psoriatic arthritis: 52-week results from a phase 3 study, FUTURE 5. Rheumatology. 2020;59:13251334
9.
National Psoriasis Foundation. Psoriasis statistics. Available from: https://www.psoriasis.org/content/statistics. Last accessed: October 2020.
10.
Mease PJ, Armstrong AW. Managing patients with psoriatic disease: the diagnosis and pharmacologic treatment of psoriatic arthritis in patients with psoriasis. Drugs. 2014;74:423-441.
11.
D'Agostino MA, Terslev L, Aegerter P, et al. Scoring ultrasound synovitis in rheumatoid arthritis: a EULAR-OMERACT ultrasound taskforce-Part 1: definition and development of a standardised, consensus-based scoring system. RMD Open. 2017;3:e000428.
12.
Eprovide. American College of Rheumatology 20/50/70 criteria (ACR20/50/70). Available from: https://eprovide.mapi-trust.org/instruments/american-college-of-rheumatology-20-50-70-criteria#:~:text=The%20ACR20%20is%20a%20composite,Health%20Assessment%20Questionnaire%20(HAQ)%5D%2C. Last accessed: October 2020.
13.
Maksymowych WP, Mallon C, Morrow S, et al. Development and validation of the Spondyloarthritis Research Consortium of Canada (SPARCC) Enthesitis Index. Ann Rheum Dis. 2009;68(6):948-953.
14.
Mease PJ, Van den Bosch F, Sieper J, Xia Y, Pangan AL, Song IH. Performance of 3 Enthesitis Indices in Patients with Peripheral Spondyloarthritis During Treatment with Adalimumab. J Rheumatol. 2017 May;44(5):599-608.
15.
Novartis Europharm Limited. Cosentyx (secukinumab): Summary of Product Characteristics. Available from: https://www.ema.europa.eu/en/medicines/human/EPAR/cosentyx Last accessed: August 2019.
16.
Girolomoni G, et al. Psoriasis: rationale for targeting interleukin-17. Br J Dermatol 2012;167:717724.
17.
Data on file. CAIN457F2310 (MEASURE 2): 5 Year Report. Novartis Pharmaceuticals Corp; September 15, 2015.
18.
Data on file. Data Analysis Report: Study CAIN457A2302E1. Novartis Pharmaceuticals Corp; November 30, 2015.
19.
Data on file. CAIN457F2310 and CAIN457F2305 Summary of 5-Year Clinical Safety in (Ankylosing Spondylitis). Novartis Pharmaceuticals Corp; May 2019.
20.
Data on file. CAIN457F2312 (FUTURE 2): 5 Year- Interim Report. Novartis Pharmaceuticals Corp; May 2019.
21.
Data on file. CAIN457F2312 Data Analysis Report. Novartis Pharmaceuticals Corp; November 2008.
22.
Data on file. CAIN457F2310 (MEASURE 1 and 2): Pooled Safety Data. Novartis Pharmaceuticals Corp; July 23, 2018.
23.
Cosentyx [Prescribing Information]. East Hanover, NJ: Novartis Pharmaceuticals Corp; 2020.
24.
Data on file. AIN457A2102 Clinical Study Report. Novartis Pharmaceuticals Corp; December 2008.
View original content:http://www.prnewswire.com/news-releases/novartis-cosentyx-shows-early-synovitis-reduction-in-patients-with-psoriatic-arthritis-in-first-of-its-kind-study-301166845.html
SOURCE Novartis Pharmaceuticals Corporation
See original here:
Novartis Cosentyx shows early synovitis reduction in patients with psoriatic arthritis in first-of-its-kind study - BioSpace
Testosterone Cypionate Market To 2026: Growth Analysis By Manufacturers, Regions, Types And Applications – The Think Curiouser
Testosterone Comments Off on Testosterone Cypionate Market To 2026: Growth Analysis By Manufacturers, Regions, Types And Applications – The Think Curiouser
DataIntelo offers a detailed report on Global Testosterone Cypionate Market. The report is a comprehensive research study that provides the scope of Testosterone Cypionate market size, industry growth opportunities and challenges, current market trends, potential players, and expected performance of the market in regions for the forecast period from 2020 to 2027. This report highlights key insights on the market focusing on the possible requirements of the clients and assisting them to make right decision about their business investment plans and strategies.
The Testosterone Cypionate market report also covers an overview of the segments and sub-segmentations including the product types, applications, companies and regions. This report further includes the impact of COVID-19 on the market and explains dynamics of the market, future business impact, competition landscape of the companies, and the flow of the global supply and consumption. The report provides an in-depth analysis of the overall market structure of Testosterone Cypionate and assesses the possible changes in the current as well as future competitive scenarios of the Testosterone Cypionate market.
Request A Free Sample Report @ https://dataintelo.com/request-sample/?reportId=76225
The published report consists of a robust research methodology by relying on primary source including interviews of the company executives & representatives and accessing official documents, websites, and press release of the companies. DataIntelo is known for its data accuracy and granular market reports.
The report is prepared with a group of graphical representations, tables, and figures which displays a clear picture of the developments of the products and its market performance over the last few years. With this precise report, it can be easily understood the growth potential, revenue growth, product range, and pricing factors related to the Testosterone Cypionate market. The report also covers the recent agreements including merger & acquisition, partnership or joint venture and latest developments of the manufacturers to sustain in the global competition of the Testosterone Cypionate market.
Key companies that are covered in this report:
PfizerCiplaSun PharmaceuticalTevaPerrigoHikma Pharmaceuticals
*Note: Additional companies can be included on request
The report covers a detailed performance of some of the key players and analysis of major players in the industry, segments, application, and regions. Moreover, the report also considers the governments policies in different regions which illustrates the key opportunities as well as challenges of the market in each region.
By Application:
Primary hypogonadismHypogonadotropic hypogonadismLate-onset hypogonadism
By Type:
200 mg/mL100 mg/mL
As per the report, the Testosterone Cypionate market is projected to reach a value of USDXX by the end of 2027 and grow at a CAGR of XX% through the forecast period (2020-2027). The report describes the current market trend of the Testosterone Cypionate in regions, covering North America, Latin America, Europe, Asia Pacific, and Middle East & Africa by focusing the market performance by the key countries in the respective regions. According to the need of the clients, this report can be customized and available in a separate report for the specific region.
You can also go for a yearly subscription of all the updates on Testosterone Cypionate market.
You can buy the complete report @ https://dataintelo.com/checkout/?reportId=76225
The following is the TOC of the report:
Executive Summary
Assumptions and Acronyms Used
Research Methodology
Testosterone Cypionate Market Overview
Testosterone Cypionate Supply Chain Analysis
Testosterone Cypionate Pricing Analysis
Global Testosterone Cypionate Market Analysis and Forecast by Type
Global Testosterone Cypionate Market Analysis and Forecast by Application
Global Testosterone Cypionate Market Analysis and Forecast by Sales Channel
Global Testosterone Cypionate Market Analysis and Forecast by Region
North America Testosterone Cypionate Market Analysis and Forecast
Latin America Testosterone Cypionate Market Analysis and Forecast
Europe Testosterone Cypionate Market Analysis and Forecast
Asia Pacific Testosterone Cypionate Market Analysis and Forecast
Middle East & Africa Testosterone Cypionate Market Analysis and Forecast
Competition Landscape
Why you should buy this report?
This report offers a concise analysis of the Testosterone Cypionate market for the last 5 years with historical data & more accurate prediction for upcoming 6 years on the basis of statistical information.
This report helps you to understand the market components by offering a cohesive framework of the key players and their competition dynamics as well as strategies.
The report is a complete guideline for the clients to arrive an informed business decision since it consists of a detailed information for better understandings of the current & future market situation.
The report also answers some of the key questions given below:
Which end-user is likely to play a crucial role in the development of the Testosterone Cypionate market?
Which regional market is expected to dominate the Testosterone Cypionate market in 2020-2027?
How is consumer consumption behavior impacting the business operations of market players in the current scenario of the Testosterone Cypionate market?
If you have any questions on this report, please reach out to us @ https://dataintelo.com/enquiry-before-buying/?reportId=76225
About DataIntelo:
We possess expertise in a variety of business intelligence domains. Our key analysis segments, though not restricted to the same, include market entry strategies, market size estimations, market trend analysis, market opportunity analysis, market threat analysis, market growth/fall forecasting, primary interviews, secondary research & consumer surveys.
We invest in our analysts to ensure that we have a full roster of experience and expertise in any field we cover. Our team members are selected for stellar academic records, specializations in technical fields, and exceptional analytical and communication skills. We also provide ongoing training and knowledge sharing to keep our analysts tapped into industry best practices.
Contact Info: Name: Alex MathewsAddress: 500 East E Street, Ontario, CA 91764, United States.Phone No: USA: +1 909 545 6473Email: [emailprotected]Website: https://dataintelo
See the article here:
Testosterone Cypionate Market To 2026: Growth Analysis By Manufacturers, Regions, Types And Applications - The Think Curiouser
Testosterone Replacement Therapy Market Size, Trends and Cost with Global Forecast by 2027 – Eurowire
Testosterone Comments Off on Testosterone Replacement Therapy Market Size, Trends and Cost with Global Forecast by 2027 – Eurowire
Testosterone Replacement Therapy Market Size And Forecast
A comprehensive overview of the Testosterone Replacement Therapy Market is recently added by Market Research Intellect to its humongous database. Furthermore, the Testosterone Replacement Therapy Market report has been aggregated by collecting informative data of various dynamics such as market drivers, restraints, and opportunities. Furthermore, this innovative report makes use of SWOT, PESTLE, and Porters Five Forces analyses to get a closer outlook on the Testosterone Replacement Therapy Market. Furthermore, the Testosterone Replacement Therapy Market report offers a detailed analysis of the latest industry developments and trending factors in the market that are influencing the market growth. Furthermore, this statistical market research repository examines and estimates the Testosterone Replacement Therapy Market at the global and regional levels. The study covers the impact of various drivers and manacles on the Testosterone Replacement Therapy Market growth opportunities over the forecast period.
Impact of Covid-19 :
During the first quarter of 2020, different global economies were badly impacted by a viral outbreak of COVID-19. This viral outbreak of the Covid-19 was later recognized as a global pandemic by the World Health Organization (WHO). COVID-19 spread in different global countries, affecting a large number of people in a short timeframe. The outburst of COVID-19 adversely hit different global economies in the world. The stringent regulations imposed by several governments, including complete lockdown and quarantine methodologies to fight against COVID-19, resulted in a massive impact on various business sectors. We at Market Research Intellect offer an informative report on the Testosterone Replacement Therapy Market which helps in making strategic decisions over the forecast period.
Competitive Landscape:
The degree of competition among leading global companies has been elaborated by examining various leading key players operating across the global regions An expert team of research analysts sheds light on various attributes such as -global market competition, market share, latest industry developments, innovative product launches, partnerships, mergers or acquisitions by leading companies in the Testosterone Replacement Therapy Market. The leading manufacturers have been analyzed by using research methodologies for getting insight views on global competition.
Following key players have been profiled with the help of proven research methodologies:
The Testosterone Replacement Therapy Market has been examined into different global market segments such as type, applications and global geographies. Each and every global market segment has been studied to get informative insights into various global regions.
Testosterone Replacement Therapy Market Segmentation:
Testosterone Replacement Therapy Market Segment by Type:
Testosterone Replacement Therapy Market Segment by Application:
Testosterone Replacement Therapy Market Segment by Global Presence:
North America Latin America Middle East Asia-Pacific Africa Europe
The report has been aggregated by using a couple of research methodologies such as primary and secondary research techniques. It helps in collecting informative pieces of professional information for deriving effective insights into the market. This informative report helps in making well informed and strategic decisions throughout the forecast period.
Key questions answered through this analytical market research report include:
What are the latest trends, new patterns and technological advancements in the Testosterone Replacement Therapy Market? Which factors are influencing the Testosterone Replacement Therapy Market over the forecast period? What are the global challenges, threats and risks in the Testosterone Replacement Therapy Market? Which factors are propelling and restraining the Testosterone Replacement Therapy Market? What are the demanding global regions of the Testosterone Replacement Therapy Market? What will be the global market size over the coming future? What are the different effective business strategies followed by global companies?
If you have any custom requirements, please let us know and we will offer you the customized report as per your requirements.
About Us:
Market Research Intellect provides syndicated and customized research reports to clients from various industries and organizations with the aim of delivering functional expertise. We provide reports for all industries including Energy, Technology, Manufacturing and Construction, Chemicals and Materials, Food and Beverage, and more. These reports deliver an in-depth study of the market with industry analysis, the market value for regions and countries, and trends that are pertinent to the industry.
Contact us:
Mr. Steven Fernandes
Market Research Intellect
New Jersey ( USA )
Tel: +1-650-781-4080
Website https://www.marketresearchintellect.com/
Read More..Global Testosterone Replacement Therapy Market Growth, Development Strategy, Trends, Demand, Future Prospects and Forecast to 2024 – PRnews Leader
Testosterone Comments Off on Global Testosterone Replacement Therapy Market Growth, Development Strategy, Trends, Demand, Future Prospects and Forecast to 2024 – PRnews Leader
The Testosterone Replacement Therapy Market study describes the current market size and market forecast, market prospects, main drivers and constraints, regulatory scenario, industry trend, PESTLE analysis, PORTER analysis, new product approvals / launch, promotion and marketing campaigns, pricing analysis , competitive environment to assist companies in decision-making. The data from the study is focused on current and historical market dynamics that assist in decisions related to investment.
Testosterone Replacement Therapy offers fundamental industry overview representing market trends, company profiles, growth drivers, market scope and Testosterone Replacement Therapy size estimation. The valuable Testosterone Replacement Therapy industry insights, type, application, deployment status and research regions are studied. A thorough analysis of gross margin view, trade news, industry plans and policies, constraints are explained. A complete Testosterone Replacement Therapy industry scenario is explained from 2014 to 2019 and forecast estimates are presented from 2020-2024. The productions, industry chain analysis, gross margin structure and deployment models are stated in detail. Top regions analysed in the report include North America, South America, Europe, Asia-Pacific, Middle East & Africa and the rest of the world. The Testosterone Replacement Therapy industry presence and maturity analysis will lead to investment feasibility and development scope.
Get A Free Sample Copy Here:
Testosterone Replacement Therapy Market Leading Players (2019-2024):
AbbVieEndo InternationalEli lillyPfizerActavis (Allergan)BayerNovartisTevaMylanUpsher-SmithFerring PharmaceuticalsKyowa KirinAcerus Pharmaceuticals
Market Segment Analysis
By Types:
GelsInjectionsPatchesOther
By Applications:
HospitalsClinicsOthers
By Region
North America
Europe
Asia-Pacific
LAMEA
Ask for Discount @:
https://www.globalmarketers.biz/discount_inquiry/discount/129647
Testosterone Replacement Therapy Industry Report addresses different regions like North America, Europe, Asia-Pacific, Middle East & Africa and Latin America. The production value, gross margin analysis, development trend, and Testosterone Replacement Therapy market positioning is explained. The industrial chain study, potential buyers, distributors and traders details are explained. The challenges to the growth and market restraints are explained. The market maturity study, investment scope and gross margin study are profiled. The production process structure, market share, manufacturing cost and Testosterone Replacement Therapy saturation analysis is covered. This will helps the industry aspirants to analysis growth feasibility and development plans.
A special highlight on cost structure, import-export scenario and sales channels of Testosterone Replacement Therapy industry is presented. The benchmarking products, dynamic market changes, upstream raw material and downstream buyers analysis are presented. The business trends, key players analysis and product segment study are explained. The regional SWOT analysis, gross margin analysis, application analysis and industry barriers are explained. The value, volume and consumption from 2019-2024 is portrayed. All the essential details like pricing structure of raw materials, labour cost, sales channels and downstream buyers are presented.
Inquire Before Buying Or Ask For Custom Requirement:
In the next segment, the forecast Testosterone Replacement Therapy industry perspective is covered. Under forecast statistics, the market value, volume and consumption forecast from 2019-2024 is explained. Testosterone Replacement Therapy regional analysis for major regions and countries in this region is stated. The study of new Testosterone Replacement Therapy industry aspirants and analysts opinions for this industry is presented. The limitations to the industry growth, market risks, Testosterone Replacement Therapy growth opportunities and market trends are viewed. The revenue, Testosterone Replacement Therapy market status, past market performance and product details are presented.
Salient Features Of The Report:
The Testosterone Replacement Therapy report serves as a vital guide in portraying present and forecast industry statistics and market size. The supply/ demand situation, gross margin view and competitive profile of top Testosterone Replacement Therapy players are presented. The Testosterone Replacement Therapy market breakdown by product, type, application and regions will provide sophisticated and precise analysis. Recent developments in Testosterone Replacement Therapy industry, growth opportunities, constraints are studied completely. Also, new product launch events, mergers & acquisitions of Testosterone Replacement Therapy , and industry plans and policies are covered.
The revenue estimates of Testosterone Replacement Therapy market based on top industry players, their product type, applications and regions is studied. The cost structures, gross margin view, sales channel analysis and value chain is explained. In the next segment, the SWOT analysis of players, cost structures, traders, distributors and dealers are listed. The forecast study on Testosterone Replacement Therapy industry will be useful for business plans and growth analysis.
To know More Details About Testosterone Replacement Therapy Market research Report @:
Contact Us:
Name: Alex White
Phone: US: +1(806)4400782/ UK: +44 33 3303 4979
Email: [emailprotected]
Read More..Key foods to boost testosterone in the body for both men and women – RSVP Live
Testosterone Comments Off on Key foods to boost testosterone in the body for both men and women – RSVP Live
Testosterone is a key hormone for both men and women, meaning it is important for everyone to pay attention to how it is being managed in our bodies.
It is now Movember, which sees men all over the world try to raise awareness and be more in tune about male health issues -- which levels of low testosterone can cause.
However, it is important for women to boost testosterone - although they produce smaller amounts, it is still a vital hormone in the female body.
If you have low levels of testosterone, you may experience symptoms such as decreased sex drive, less energy, weight gain, feelings of depression, moodiness, low self-esteem and thinner bones amongst other things.
One way to boost testosterone in the body is by eating the correct foods which will help production of the hormone.
The Marian Gluck Clinic has shared the top testosterone-boosting foods to include in your diet - all of which can be incorporated in different recipes and mealtimes.
Garlic contains a compound called allicin which can be useful for lowering your cortisol levels. Cortisol is produced in the adrenal gland, which is where testosterone is produced. When your body is under stress it produces cortisol and this has an impact on other bodily functions, including the production of testosterone. Therefore, by reducing the amount of cortisol in your system you allow testosterone to be produced more effectively by the adrenal gland. So whilst garlic doesnt itself act as a testosterone boosting food, it is a cortisol reducer and by association boosts testosterone levels.
Almonds contain high levels of the mineral zinc which is known to raise testosterone levels in people who are zinc deficient. If you are low in zinc this could stop the pituitary gland from releasing some of the key hormones for stimulating testosterone production. By eating zinc rich foods, you can help make sure this doesnt happen and avoid a reduction in your testosterone levels.
Spinach has long been considered one of the best testosterone boosting foods around. One of the most popular super foods, it was Popeyes food of choice for a reason! Spinach is a natural source of magnesium which has been shown to correlate positively with testosterone levels. Spinach also contains vitamin B6 and Iron which are both excellent testosterone boosters.
Lemons, along with other citrus fruits, are great testosterone boosting foods! Much like garlic they help to lower your levels of cortisol which means testosterone can be more readily produced. Not only that but they contain vitamin A which is required for the production of testosterone and can help lower estrogen level which means testosterone can be more effective.
Bananas contain an enzyme called bromelain which is known to help boost testosterone levels. Bananas are also excellent for maintaining energy levels and reducing antioxidants so make the perfect on the go snack.
Porridge oats are an excellent source of B Vitamins which are key for good testosterone production. There are a number of different B Vitamins, many of which are found in testosterone boosting foods. One B Vitamin which plays a very direct role in testosterone production is Vitamin B6 which supresses the production of estrogen, thereby helping testosterone levels to rise. Oats are an excellent source of a variety of B Vitamins and therefore are one of a range of excellent testosterone boosting foods.
If you think you may have low testosterone levels seek medical advice. Your symptoms may be down to a hormonal imbalance. The Marion Gluck Clinic treat a range of symptoms that can be reduced and even irradicated by bio-identical hormonal replacement treatment.
Read the original here:
Key foods to boost testosterone in the body for both men and women - RSVP Live
Diabetes Awareness Month: Diabetes, ED, & Infertility – University of Utah Health Care
Testosterone Comments Off on Diabetes Awareness Month: Diabetes, ED, & Infertility – University of Utah Health Care
Nov 04, 2020 7:00 AM
November is National Diabetes Awareness Month. As we aim to raise awareness about diabetes, we encourage our patients re maintain a health and active lifestyle. As mens health specialists, we are also here to raise awareness of diabetes and male infertility. Many men do not know that erectile dysfunction (ED) is a symptom of diabetes.
You can prevent many cases of diabetes and its complications by a nutritious diet, regular physical activity, maintaining a healthy body weight, and avoiding tobacco use.
Diabetes is a serious condition. Type 1 diabetes, which can develop at any age, occurs when your body does not produce insulin. Insulin is a hormone that helps your body digest glucose (sugar). Type 2 diabetes is a chronic condition. The body struggles with processing glucose and does not produce enough insulin or resists insulin.
Making a few lifestyle changes can help you avoid the serious health complications that can occur with diabetes.
Stay Physically Active Exercise helps maintain a healthy weight. It can also lower blood sugar levels.
Eat a Healthy Diet Foods high in fiber, such as vegetables, beans and whole grains, can lower your risk of diabetes and heart disease.
Drink More Water Stick with water as your main beverage. Avoid soda and other sugary drinks.
Quit Smoking Smoking not only increases the risk of diabetes but can lead to other serious health conditions, such as heart disease and cancer.
As mens health specialists, we see many patients with diabetes. While many men do not realize that diabetes is contributing to their erectile problems, 66 percent of men with diabetes have erectile dysfunction. In fact, half of all men with diabetes will experience ED within 10 years of their diagnosis.
High blood sugar levels can damage the nerves that control sexual stimulation. They can also damage blood vessels. These blood vessels are necessary to provide enough blood flow to the penis to achieve and maintain an erection.
Many patients are not aware that ED can be a symptom of diabetes. We frequently see men come to us for ED and end up being diagnosed with diabetes. We can see this after we run blood work.
Diabetes can also result in low testosterone levels. If you have low testosterone, you can have a drop in sex drive. Low testosterone can also lead to erectile dysfunction and other issues. These issues could be a decrease in bone density and potentially cardiovascular disease.
Learn about the treatment for erectiledysfunction.
Diabetes can also impact a mans fertility. The damaged nerves that diabetes can cause can lead to conditions like retrograde ejaculation and anejaculation, where the semen does not come out the right direction.
We may also see abnormally low sperm count or mobility in men who dont manage their diabetes. If you are having difficulty conceiving, make an appointment with a urologist specially trained in male fertility.
Also, consider that diabetes can affect mens health. Contact us for an appointment if you have any questions. We are always happy to help.
Go here to read the rest:
Diabetes Awareness Month: Diabetes, ED, & Infertility - University of Utah Health Care
Trans women are now banned from playing in World Rugby | TheHill – The Hill
Testosterone Comments Off on Trans women are now banned from playing in World Rugby | TheHill – The Hill
Rugby is on the rise, according to a new report from World Rugby on the sports strong growth in both established and emerging rugby nations during 2019. And a large part of that unprecedented growth is driven by women, according to the sport's world governing body.
Unprecedented growth is driven by uplift in womens interest and participation in the sport.#womeninrugby #Unstoppables #TryAndStopUs pic.twitter.com/WTBtlsKbgb
But not all women will be allowed to play, under new guidelines released last month which have banned transgender women from playing womens rugby. Any man or woman who transitioned post-puberty and has taken testosterone during puberty or adolescence is banned from the sport. The one exception is for transgender men, who must obtain a Therapeutic Use Exemption to the leagues prohibition of testosterone use and provide confirmation of physical ability to play.
READ MORE LIKE THIS FROM CHANGING AMERICA
BOOKS ON RACE AND DISCRIMINATION IN AMERICA BECOME BESTSELLERS
MICHELLE OBAMA OPENS UP LIKE NEVER BEFORE IN NEW NETFLIX DOCUMENTARY
WASHINGTON NFL FOOTBALL TEAM TO CHANGE CONTROVERSIAL NAME, LOGO
HOW ONE PHILADELPHIA SPORTS TEAM IS HONORING BLACK LIVES TAKEN BY POLICE
World Rugby will permit transgender players to play in a currently nonexistent mixed gender category, which the organization has committed to exploring as an option along with its unions, associations, International Rugby Players and trans-advocate groups Gendered Intelligence and International Gay Rugby.
But national rugby unions for some of the top teams in the sport, including New Zealand, England, Canada and the United States, are rejecting the ban.
"World Rugby's guidelines don't apply to our community game here in New Zealand and we're committed to ensuring the game's inclusive and safe for all. We know there is more work to do and we want to get it right. We will be consulting more broadly and doing more work to develop guidelines that are relevant for New Zealand communities," New Zealand Rugby's Chief Transformation Officer Nicki Nicol told NZME.
America is changing faster than ever! Add Changing America to your Facebook or Twitter feed to stay on top of the news.
"Rugby Canada has made clear that the draft guidelines, as currently presented, are not policy that can or will be adopted should they move forward. Rugby participation in Canada will continue to be guided by the existing Trans Inclusion Policy and the Canadian Charter of Rights & Freedoms," said the Canadian Union in a statement.
In a statement, World Rugby clarified that the guidelines will apply to all World Rugby tournaments at the international level, but national unions have jurisdiction on a domestic level. The decision comes as the rights of transgender athletes are being questioned across the world and the country.
For Grace McKenzie, a transgender woman on the Golden Gate Womens Rugby Club in San Francisco, that leaves her wondering whether she has a future in rugby. She started a petitionthis summer when a draft of the guideline change was leaked and has gathered more than 18,000 signatures calling to keep the sport open to transgender women.
Much of the organization's rationale is based on the risk of injury to players, as outlined in the guidelines, as well as some level of performance advantages. Experts say there is little to no scientific research about the performance of elite transgender athletes, but World Rugby cited studies indicating residual advantages for transgender women who undergo testosterone suppression.
Its about policing female bodies, said Verity Smith, 39, of Britain, a transgender man who competed on womens teams for 26 years before transitioning and was a silent observer at the World Rugby deliberations, told the New York Times. These governing bodies automatically assume that all female-bodied athletes are not as strong as male-bodied ones, when that simply isnt the case.
Research also shows that access to puberty blockers can decrease the risk of suicide in transgender teens. And while that choice might save their lives, it may cost them a future in a sport they will never get to love as much as McKenzie now does.
Trans women who are starting their journey with the game are going to be dissuaded to participate at a big level in rugby or to push their performance from going to those higher levels or to play at all, McKenzie told NBC News. I think thats sort of the larger tragedy thats coming up.
READ MORE LGBTQ+ STORIES FROM CHANGING AMERICA
IDAHOS CONTROVERSIAL NEW TRANS RIGHTS BILLS FACE LEGAL CHALLENGES
ANTI-GAY GOP LAWMAKER VOTED AGAINST CORONAVIRUS BILL BECAUSE IT REDEFINED FAMILY
SOUTH CAROLINA COURT STRIKES DOWN LAW BANNING LGTBQ+ SEX ED
WHAT IS THE LEGACY OF PETE BUTTIGIEGS HISTORIC RUN AS AMERICAS FIRST GAY PRESIDENTIAL CANDIDATE?
SPORTS SAVED MY LIFE. TRANSGENDER ATHLETES SHOULD BE ABLE TO HAVE THAT EXPERIENCE TOO
GAY CONVERSION THERAPY OFFICIALLY BANNED IN VIRGINIA
See the original post:
Trans women are now banned from playing in World Rugby | TheHill - The Hill
The Male Menopause Treatment market to substantiate from 2019 to 2029 – TechnoWeekly
Testosterone Comments Off on The Male Menopause Treatment market to substantiate from 2019 to 2029 – TechnoWeekly
Male menopause refers to the hormonal imbalance or hormonal changes in the males due to which there is a reduction in the testosterone levels in the males. There are various symptoms of male menopause. Some of the symptoms include low energy, increasing body fat, decreasing bone density, erectile dysfunction, infertility, etc. There are many other changes associated with the testosterone level changes. Some of the major changes observed in males are a growth of the muscle mass, lowering of voice and changes related to sexual functioning. The male menopause can be treated by changing the lifestyle habits or it can be treated by taking testosterone replacement therapy. Healthy lifestyle habits such as taking a healthy diet. Having proper nap etc. can treat the male menopause treatment market.
Increasing research and developmental activities is one of the major factor driving the growth of male menopause treatment market. The rate of smoking is increasing, which can lead to hormonal imbalance, increasing the growth of the male menopause treatment market. Large intake of drugs and alcohol is another important factor, which can be responsible for the reduction of testosterone level and is expected to increase the growth of male menopause treatment market. Increasing adoption of poor lifestyle habits such as a high intake of junk food, lack of exercise, etc. can be responsible for increasing the growth of male menopause treatment market. Increasing stress due to daily hectic routine can also increase the growth of male menopause treatment market. Other factors, such as increasing healthcare awareness, technological advancements leading to better diagnostic rates, increasing disposable income, modernization of the Indian society, etc. can be responsible for the significant growth of male menopause treatment market.
There are various side effects of male menopause treatment drugs, which can hinder the growth of male menopause treatment market. Lack of awareness in some of the developing regions can restrain the growth of male menopause treatment market.
To remain ahead of your competitors, request for a sample[emailprotected]
https://www.persistencemarketresearch.com/samples/28771
The global Male Menopause Treatment market is segmented on basis of drug type, Source of administration, distribution channel and geographic region:
Based on the drug type, the Male Menopause Treatment has been divided into testosterone supplements and vitamin supplements. Testosterone supplements can be given in various forms and are expected to hold the largest revenue share in the male menopause treatment market. Testosterone replacement therapy is the most common therapy, used for the treatment of male menopause treatment market. Amongst all the testosterone supplements, DHEA and D-Aspartic acid are expected to hold the maximum revenue share in the male menopause treatment market. Based on the route of administration, the male menopause treatment market has been divided into oral administration and subcutaneous administration. Oral route of administration is expected to hold the maximum revenue share in the male menopause treatment market as it is the most common form of administration used by the male patients. Based on the distribution channel, the male menopause treatment has been divided into hospital pharmacies, retail pharmacies, drug stores, and online pharmacies. Drug stores and hospital pharmacies are expected to hold the maximum revenue share in the male menopause treatment market.
To receive extensive list of important regions, Request Methodology here @
https://www.persistencemarketresearch.com/methodology/28771
On the basis of geography, the global Male Menopause Treatment market is studied and divided into a few key regions such as North America, Latin America, Europe, Asia, Middle East & Africa and Oceania. North America is expected to hold a large revenue share in global Male Menopause Treatment market because of the presence of a large number of research and developmental activities and availability of technological advancement in the field of healthcare. Europe is expected to hold the second largest market share because of the presence of the large population. The Asia Pacific can also show a large revenue share in the Male Menopause Treatment market because of the increasing healthcare awareness
There are many companies manufacturing Male Menopause Treatment drugs. Some of the big pharmaceutical companies involved in the manufacture of Male Menopause Treatment drugs are Thermofisher Scientific Inc., Abbott, Sun Pharmaceuticals Industries Ltd., Perrigo Company plc, Bayer AG and many other companies.
You Can Request for TOC[emailprotected]
https://www.persistencemarketresearch.com/toc/28771
Explore Extensive Coverage of PMR`s
Life Sciences & Transformational HealthLandscape
About us:
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics andmarket research methodologyto help businesses achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.
Our client success stories feature a range of clients from Fortune 500 companies to fast-growing startups. PMRs collaborative environment is committed to building industry-specific solutions by transforming data from multiple streams into a strategic asset.
Contact us:
Naved BegPersistence Market ResearchAddress 305 Broadway, 7th Floor, New York City,NY 10007 United StatesU.S. Ph. +1-646-568-7751USA-Canada Toll-free +1 800-961-0353Sales[emailprotected]Websitehttps://www.persistencemarketresearch.com
Continued here:
The Male Menopause Treatment market to substantiate from 2019 to 2029 - TechnoWeekly
How to Find a Fitness Accountability Buddy – Lifehacker
Fitness Comments Off on How to Find a Fitness Accountability Buddy – Lifehacker
Photo: Flamingo Images (Shutterstock)
A workout buddy is a wonderful thing to have. If theyre just a smidge stronger or faster than you, theyll inspire you to push yourself just a little bit more. But its hard to find someone whos at the exact right level of fitnessand whose company you enjoy. The better solution might be to find yourself an accountability buddy.
In this partnership, you and the other person dont have to be matched on any physical metric. You just have to share the goal of working out consistently, and keep each other on track. Weve discussed this concept before with regard to yourfinances andworking from home. Its the same idea with fitness.
It looks something like this: you and your friendor a small group of friendsagree on your goals moving forward, and how youll met them. Then you check in with each other regularly to make sure youre all sticking with what you planned.
This can be a simple check-in by text: I did my morning workout, did you? Or you and your friend can agree to do the same workout program. Maybe you set up a Zoom call and do your workouts at the same time. Or maybe you just both hit play on an exercise video at the same time and talk afterward about how it went. The important thing is that youre accountable to somebody. The two of you can encourage each other, and you know that if you dont do your part, youll be leaving them in the lurch.
It doesnt matter if theyre stronger or faster than you. Youll be connecting on a level of motivation and consistency, so pick somebody who will push you to do your best. That friend who is just a little better at getting up in the morning, perhaps?
G/O Media may get a commission
If you tend to talk yourself out of workouts, dont pair up with somebody who will just encourage your laziness. On the other hand, if you sometimes go a little too hard, pick somebody who will remind you of the importance of rest days rather than someone who will egg you on.
You might already be thinking of someone in your life who you might like to pair up with. But if nobody comes to mind, there are a few places you can start looking.
First, check fitness communities on places like Reddit (r/xxfitness and r/weightroom, for example, or find a group that caters to your favorite sport or activity). Sometimes people post in those groups asking for buddies or asking to form a small accountability group. You can also just start posting in the daily threads about what youre doing, and chances are youll start to make friends that way too.
Similarly, there are forums out there for every sport and pastime. Peloton allows people to find each other and form groups and friendships, for example. Search Facebook for your location and your favorite outdoor activity and youll find fellow trail runners or rock climbers or like-minded fans of whatever you love to do. Another option is to look for Discord servers where people discuss fitness or the specific sport youre interested in.
You can also use other social media platforms, like Instagram, to start posting about what you do and checking in with friends. Half the point of having an accountability buddy is that you have to decide what it is you want to do, and state those intentions out loud. The buddy is just an audience for you to speak to; your intentions and your commitment are really coming from within you.
View post:
How to Find a Fitness Accountability Buddy - Lifehacker